Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Durvalumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Medimmune (AstraZeneca)
By Type:
10mL Injection
24mL Injection
By Application:
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Durvalumab Market Overview 2018-2029
-
1.1 China Durvalumab Industry Development Overview
-
1.2 China Durvalumab Industry Development History
-
1.3 China Durvalumab Industry Market Size (2018-2029)
-
1.4 China Durvalumab Market Analysis by Type from Production Side
-
1.4.1 China Durvalumab Production Volume, Production Value and Growth Rate of 10mL Injection (2018-2029)
-
1.4.2 China Durvalumab Production Volume, Production Value and Growth Rate of 24mL Injection (2018-2029)
-
1.5 China Durvalumab Market Analysis by Application from Consumption End
-
1.5.1 China Durvalumab Sales Volume, Sales Value and Growth Rate of Locally Advanced Urothelial Carcinoma (2018-2029)
-
1.5.2 China Durvalumab Sales Volume, Sales Value and Growth Rate of Metastatic Urothelial Carcinoma (2018-2029)
-
1.5.3 China Durvalumab Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Durvalumab Market Analysis by Region
-
1.6.1 North China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Durvalumab Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Durvalumab Market Size and Growth Rate from 2018-2029
Chapter 2 China Durvalumab Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Durvalumab Market Status and Competition at home and abroad in 2023
-
2.2.2 China Durvalumab Market Status and Competition Analysis in 2023
-
2.2.3 China Durvalumab Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Durvalumab Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Durvalumab Industry Development
Chapter 3 DurvalumabIndustry Chain Analysis
-
3.1 Durvalumab Industry Chain
-
3.2 Durvalumab Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Durvalumab Market
-
3.3 Durvalumab Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Durvalumab Market
Chapter 4 China Durvalumab Market, by Type
-
4.1 China Durvalumab Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Durvalumab Total Production Volume and Growth Rate from Production Side
-
4.5 China Durvalumab Production Volume and Growth Rate, by Type
-
4.5.1 China Durvalumab Production Volume and Growth Rate of 10mL Injection
-
4.5.2 China Durvalumab Production Volume and Growth Rate of 24mL Injection
Chapter 5 China Durvalumab Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Durvalumab Total Market Size and Growth Rate from Consumption End
-
5.5 China Durvalumab Market Size and Growth Rate, by Application
-
5.5.1 China Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma
-
5.5.2 China Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma
-
5.5.3 China Durvalumab Market Size and Growth Rate of Other
Chapter 6 China Durvalumab Market, by Region
-
6.1 China Durvalumab Production Volume and Production Value, by Region
-
6.2 China Durvalumab Sales Volume and Sales Value, by Region
Chapter 7 North China Durvalumab Market Analysis
-
7.1 North China Durvalumab Market, by Type
-
7.2 North China Durvalumab Market, by Application
Chapter 8 Central China Durvalumab Market Analysis
-
8.1 Central China Durvalumab Market, by Type
-
8.2 Central China Durvalumab Market, by Application
Chapter 9 South China Durvalumab Market Analysis
-
9.1 South China Durvalumab Market, by Type
-
9.2 South China Durvalumab Market, by Application
Chapter 10 East China Durvalumab Market Analysis
-
10.1 East China Durvalumab Market, by Type
-
10.2 East China Durvalumab Market, by Application
Chapter 11 Northeast China Durvalumab Market Analysis
-
11.1 Northeast China Durvalumab Market, by Type
-
11.2 Northeast China Durvalumab Market, by Application
Chapter 12 Southwest China Durvalumab Market Analysis
-
12.1 Southwest China Durvalumab Market, by Type
-
12.2 Southwest China Durvalumab Market, by Application
Chapter 13 Northwest China Durvalumab Market Analysis
-
13.1 Northwest China Durvalumab Market, by Type
-
13.2 Northwest China Durvalumab Market, by Application
Chapter 14 Company Profiles
-
14.1 Medimmune (AstraZeneca)
-
14.1.1 Medimmune (AstraZeneca) Company Profile
-
14.1.2 Medimmune (AstraZeneca) Durvalumab Market Performance
-
14.1.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Durvalumab Industry Research Conclusions
-
15.2 Durvalumab Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Durvalumab Industry Market Size (2018-2029)
-
Figure China Durvalumab Production Volume, Production Value and Growth Rate of 10mL Injection (2018-2029)
-
Figure China Durvalumab Production Volume, Production Value and Growth Rate of 24mL Injection (2018-2029)
-
Figure China Durvalumab Sales Volume, Sales Value and Growth Rate of Locally Advanced Urothelial Carcinoma (2018-2029)
-
Figure China Durvalumab Sales Volume, Sales Value and Growth Rate of Metastatic Urothelial Carcinoma (2018-2029)
-
Figure China Durvalumab Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure Central China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure South China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure East China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Durvalumab Market Size and Growth Rate from 2018-2029
-
Figure Durvalumab Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Durvalumab Market Share by Type in 2018
-
Figure China Durvalumab Market Share by Type in 2023
-
Figure China Durvalumab Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Durvalumab Production Volume and Growth Rate of 10mL Injection (2018-2023)
-
Figure China Durvalumab Production Volume and Growth Rate of 24mL Injection (2018-2023)
-
Figure China Durvalumab Market Share by Application in 2018
-
Figure China Durvalumab Market Share by Application in 2023
-
Figure China Durvalumab Total Market Size and Growth Rate from Consumption End
-
Figure China Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma (2018-2023)
-
Figure China Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma (2018-2023)
-
Figure China Durvalumab Market Size and Growth Rate of Other (2018-2023)
-
Table China Durvalumab Production Volume by Region (2018-2023)
-
Table China Durvalumab Production Volume Share by Region (2018-2023)
-
Figure China Durvalumab Production Volume Share by Region (2018-2023)
-
Table China Durvalumab Production Value by Region (2018-2023)
-
Table China Durvalumab Production Value Share by Region (2018-2023)
-
Figure China Durvalumab Production Value Share by Region (2018-2023)
-
Table China Durvalumab Sales Volume by Region (2018-2023)
-
Table China Durvalumab Sales Volume Share by Region (2018-2023)
-
Figure China Durvalumab Sales Volume Share by Region (2018-2023)
-
Table China Durvalumab Sales Value by Region (2018-2023)
-
Table China Durvalumab Sales Value Share by Region (2018-2023)
-
Figure China Durvalumab Sales Value Share by Region (2018-2023)
-
Table North China Durvalumab Production Volume by Type (2018-2023)
-
Table North China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure North China Durvalumab Production Volume Share by Type (2018-2023)
-
Table North China Durvalumab Sales Volume by Application (2018-2023)
-
Table North China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure North China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table Central China Durvalumab Production Volume by Type (2018-2023)
-
Table Central China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure Central China Durvalumab Production Volume Share by Type (2018-2023)
-
Table Central China Durvalumab Sales Volume by Application (2018-2023)
-
Table Central China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure Central China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table South China Durvalumab Production Volume by Type (2018-2023)
-
Table South China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure South China Durvalumab Production Volume Share by Type (2018-2023)
-
Table South China Durvalumab Sales Volume by Application (2018-2023)
-
Table South China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure South China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table East China Durvalumab Production Volume by Type (2018-2023)
-
Table East China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure East China Durvalumab Production Volume Share by Type (2018-2023)
-
Table East China Durvalumab Sales Volume by Application (2018-2023)
-
Table East China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure East China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table Northeast China Durvalumab Production Volume by Type (2018-2023)
-
Table Northeast China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure Northeast China Durvalumab Production Volume Share by Type (2018-2023)
-
Table Northeast China Durvalumab Sales Volume by Application (2018-2023)
-
Table Northeast China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table Southwest China Durvalumab Production Volume by Type (2018-2023)
-
Table Southwest China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure Southwest China Durvalumab Production Volume Share by Type (2018-2023)
-
Table Southwest China Durvalumab Sales Volume by Application (2018-2023)
-
Table Southwest China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table Northwest China Durvalumab Production Volume by Type (2018-2023)
-
Table Northwest China Durvalumab Production Volume Share by Type (2018-2023)
-
Figure Northwest China Durvalumab Production Volume Share by Type (2018-2023)
-
Table Northwest China Durvalumab Sales Volume by Application (2018-2023)
-
Table Northwest China Durvalumab Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Durvalumab Sales Volume Share by Application (2018-2023)
-
Table Medimmune (AstraZeneca) Company Profile
-
Table Medimmune (AstraZeneca) Durvalumab Revenue, Price and Gross (2018-2023)
-
